InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding InflaRx N.V. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 37 | 42 | +5 |
| Shares | 18.5M | 19.0M | +478.2K (+2.6%) |
| Value | $82.7M | $56.8M | −$26.0M (−31.4%) |
New holders (10)
Institutions that held InflaRx N.V. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 688,604 | $2.05M | 0.76% |
| Boothbay Fund Management, LLC | 141,652 | $422.1K | 0.01% |
| Virtu Financial LLC | 23,138 | $69.0K | 0.01% |
| XTX Topco Ltd | 14,588 | $43.5K | 0.01% |
| Citadel Advisors LLC | 12,868 | $38.3K | 0.00% |
| Marshall Wace, LLP | 12,501 | $37.3K | 0.00% |
| Two Sigma Investments, LP | 12,425 | $37.0K | 0.00% |
| Group One Trading, L.P. | 3,831 | $11.4K | 0.00% |
| Cubist Systematic Strategies, LLC | 2,800 | $8.34K | 0.00% |
| UBS Group AG | 463 | $1.38K | 0.00% |
Sold out (5)
Institutions that held InflaRx N.V. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 34,891 | $155.6K |
| Jump Financial, LLC | 22,900 | $102.1K |
| Mercer Global Advisors Inc | 10,000 | $45.0K |
| Bank of America Corp | 7,945 | $35.4K |
| Royal Bank of Canada | 893 | $4.00K |